SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-19-060139
Filing Date
2019-11-06
Accepted
2019-11-05 17:40:36
Documents
3
Group Members
TAKEDA VENTURES, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G a19-21965_1sc13g.htm SC 13G 78047
2 EX-99.1 a19-21965_1ex99d1.htm EX-99.1 1968
3 EX-99.2 a19-21965_1ex99d2.htm EX-99.2 10859
  Complete submission text file 0001104659-19-060139.txt   92494
Mailing Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668
Business Address 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU TOKYO M0 103-8668 81332782111
TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90744 | Film No.: 191194460
SIC: 6770 Blank Checks